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1. Introduction 
The presence of a Ca2’-dependent protease in the 
soluble fraction of rat brain extracts which has opti- 
mum activity at neutral pH was reported in [ 11. 
Despite the fact that protease activities closely related 
to the rat brain enzyme have been detected in many 
mammalian tissues [2,3] and purified from porcine 
[4] and chicken [5] skeletal muscle, little is known 
about the function of these proteases in the cell. 
Such protease activities may be involved in regula- 
tion of muscle fiber turnover since they disrupt the 
myofibril Z-line [4,6]. Ca2+-dependent protease activ- 
ities which degrade filamin-actin complexes [7] and 
microtubule-associated assembly factors [X] have also 
been described. Thus, Ca2’-dependent proteases may 
be responsible for initiating turnover of a variety of 
cellular ultrastructures. 
One of the major problems associated with assessing 
the physiological significance of these protease activ- 
ities in the cell is that they require a much higher 
concentration of free-Ca2+ than is normally present in 
muscle cells [ 1,4]. In the following studies, two Ca2+- 
dependent protease activities from canine cardiac 
extracts were separated and partially purified. Although 
many properties of the two activities were similar, 
one of the forms was found to be active at free-Ca2+ 
concentrations which may be attained in muscle cells 
during contraction. 
2. Experimental 
2.1 . Pro tease assay 
Protease activity was determined using a modifica- 
tion of the assay in [lo] which is based on the reac- 
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tion of fluorescamine with primary amine groups 
produced by proteolytic cleavage of protein substrates. 
The method used here was that in [l l] except that 
activity was determined at 20°C rather than 30°C 
since the enzyme was more stable at the lower tempera- 
ture, and all protease assays except where noted were 
done in the presence of 5 mM CaC12, at pH 6.8. A 
unit of protease activity is defined as the amount of 
enzyme which produces one micromole of glycine- 
equivalent free amine from succinylated bovine serum 
albumin per minute at 20°C and pH 6.8. 
2.2, Preparation of canine cardiac pro teases 
Hearts were excised from mongrel dogs anesthetized 
with secobarbital. The hearts were allowed to beat in 
ice-cold isotonic saline solution for a few minutes to 
expel excess blood. They were then immediately 
placed in a -70°C freezer and stored for up to several 
months before being used. All purification steps unless 
otherwise noted were performed at 5°C. The hearts 
were thawed and trimmed of fat, minced in a com- 
mercial meat grinder and mixed with 2 vol. 50 mM 
imidazole-HCl, 5 mM EDTA, 42 mM mercapto- 
ethanol (pH 7.4) (buffer A) containing in addition 
0.25 M sucrose. The mixture was blended in a Waring 
blender using two 10 s bursts at low speed. The homog- 
enate was centrifuged at 14 000 X g for 20 min, and 
the supernatant was mixed with 500 ml DEAE- 
Sepharose CL-6B equilibrated with buffer A. The 
DEAE-Sepharose was poured into a 5.0 cm diam. 
column, and the gel was washed with 800 ml buffer 
A containing 0.1 M NaCl. The protease activity was 
then eluted with buffer A containing 0.4 M NaCl. 
Cold, neutralized, saturated ammonium sulfate 
(1.5 vol.) was added to the pooled protease fractions. 
After 20 min at O”C, the precipitate was collected by 
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~el~trifugation at 10 000 X g for 20 min. The resulting 
precipitate was resuspended in buffer A to 20 ml final 
vol. and dialyzed against 1 1 buffer A for 60 h. The 
insoluble material in the dialyzed preparation was 
removed by centrifugation, and the preparation was 
applied to a 2.6 X 86 cm column of Ultrogel AcA 34 
equilibrated in buffer A. The pooled column fractions 
containing protease activity from UItrogel chromatog- 
raphy were applied to a I .6 X 12 cm column of 
DEAE-Sephadex A-25 equilibrated in 50 mM imida- 
zole--HCl, 5 mM EDTA, 1 mM dithiot~eitol (pH 7.4) 
(buffer B), and the column was washed with 90 ml 
buffer B. The protease activities were eluted with a 
200 ml O-O.5 M NaCl gradient in buffer B. The pro- 
tease peaks from this step were pooled separately and 
dialyzed overnight against buffer B containing 50% 
(v/v) glycerol and stored at -2O’C. 
2.3. ED TA -free pro tease samples 
Prior to determining the CaZf requirements of the 
protease, samples of peak I and peak II protease were 
exchanged for EDTA-free buffer B containing 0.2 M 
NaCI by gel filtration on Sephadex C-50, medium 
mesh. The rapid method of [12] was used. The sample 
size was 0.2 ml, and the Sephadex G-50 wet gel vol. 
2.0 ml >70% of the activity of both proteases was 
recovered. It was estimated that <l% of the EDTA 
remained in the sample after filtration, based on 
retention of [32P] ATP in the gel matrix using the 
same gel bed volume and sample size (D. Brown, 
unpublished observation). 
2.4.‘Other methods 
Protein concentrations for monitoring protease 
purification were determined by the modification 
1131 of the method in [14]. Proteins were detected 
in chromatography fractions by the rapid fluoro- 
metric method in [ 151. 
2S.Materids 
Grade II imidazole was obtained from Sigma 
Chemical Co. and was recrystallized from acetone 
before being used in buffers. DEAE-Sepharose 
CL-6B, DEAE-Sephadex A-25 and Sephadex G-50 
were products of Pharmacia Fine Chemicals obtained 
through Sigma. UItrogel AcA 34 was purchased from 
LKB. Bovine serum albumin (fraction V, fatty acid- 
free), leupeptin, soybean trypsin inhibitor, and pro- 
tamine (grade IV, free base) were obtained from 
Sigma. Fluorescamine was purchased from Aldrich 
Chemical Co. All other chemicals used were of 
reagent grade. 
Table 1 






















Protein Purifica- Recovery 
(mg) tion (5% yield) 
17 098 (l)a (100)a 
1680 10.2 100 
988 14.3 83 
201 41.3 56 
7.65 (146)b (6.5)b 
5.77 (1298)b (44)b 
a Based on activity recovered from DEAE-Sepharose chromatography, since there 
was a protease inhibitor in the extract (see text) 
b Based on total protease activity in the DEAE-Sepharose fraction 
The calciumdependent proteases were partially purified from 510 g dog heart by 
the procedure in section 2 
I30 
Volume 109, number 1 FEBS LETTERS January 1980 
3. Results 
3 .l . Purification of proteases 
Two fractions of canine cardiac Ca”-dependent 
protease were partially purified utilizing the purifica- 
tion scheme described above (table 1). Peak I protease 
eluted from DEAE-Sephadex at 60 mM NaCl (fig.1) 
and was purified 145fold on the basis of total protease 
activity. Peak II protease eluted at 160 mM NaCl 
(fig.l), and was purified 1298-fold. The total protease 
activity in the 14 000 X g supernatant was estimated 
from the protease activity recovered from DEAE- 
Sepharose chromatography. This estimation is neces- 
sary since canine cardiac extracts contained a potent 
inhibitory activity presumably related to the factors 
described in rabbit cardiac [ 161 and bovine cardiac 
[ 171 extracts which made it impossible to detect 
protease activity. 
3.2. Molecular weights of proteases 
The molecular weights of the isolated proteases 
were estimated by analytical gel filtration on an 
Ultrogel AcA 34 column. As shown in fig.2, panel A, 
the individual proteases were indistinguishable on the 
10 20 30 40 50 60 
FRACTION NUMBER 
Fig. 1. Separation of dog heart peak I and peak II proteases 
on DEAE-Sephadex A-25 chromatography. Pooled protease 
fractions from the Ultrogel AcA 34 gel filtration step (table 1) 
were applied to a DEAE-Sephadex A-25 column and chro- 
matography performed as in section 2. Column fractions were 
assayed for protease activity (0) using succinylated bovine 
serum albumin as substrate. Relative protein concentrations 
in column fractions (m) were determined as in [ 151, and are 
expressed as glycine-equivalent free amine concentration in 
the fractions. The chloride concentrations (. . . .) of column 
fractions were determined with a Corning Model 920 M 
chloridometer. 
FRACTION NUMBER EUJTION VOLUME (ml) 
Fig.2. Gel filtration of peak I and peak 11 proteases. Protease 
samples were subjected to gel filtration on a calibrated 
1.0 X 26 cm Ultrogel AcA 34 column equilibrated in 50 mM 
imidazole-HCl, 5 mM EDTA, 200 mM NaCl, 42 mM mercapto- 
ethanol (pH 7.4). Peak I and peak II proteases were applied 
at 1.3 units/ml and 3.4 units/ml, respectively. Samples (10 ~1) 
of column fractions were assayed for protease activity using 
succinylated bovine serum albumin as a substrate. (A) Gel 
filtration profile of peak I protease (0) and peak II protease 
(A). (B) Estimated molecular weight of the protease forms. 
The calibration standards used were: (1) catalase; (2) aldolase; 
(3) lactoperoxidase; (4) chymotrypsinogen A. The arrow 
marks the elution volume of the proteases. 
basis of their gel filtration profiles. The apparent 
molecular weight of the protease forms was 135 000 
(fig.2, panel B). 
3.3. pH optima of proteases 
Both proteases forms had maximum activity at 
pH 7.0 using succinylated protamine as substrate (not 
shown). Peak I protease had a broader pH profile and 
slightly more activity at pH 5.5-7.0 than peak II 
protease. Similar results were reported for peak I and 
peak II proteases from rabbit skeletal muscle [I 11. 
3.4. Effect of protease inhibitors 
In order to further characterize the two protease 
forms, the effect of various protease inhibitors on the 
two activities was studied. At 5 mM, EDTA,Nethyl- 
maleimide and iodoacetamide completely inhibited 
both protease forms. At 20 PM, leupeptin also totally 
inactivated both forms. In a separate experiment, it 
was shown that peak I and peak II proteases were 
inhibited 50Y0 in the presence of 1.6 PM leupeptin 
and 2.5 PM leupeptin, respectively. Phenylmethyl- 
sulfonyl fluoride at 1 mM inhibited peak I protease 
45% and peak II protease 52%, while soybean trypsin 
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Pig.3. Effect of calcium on EDTA-free dog heart proteases. 
Samples of peak I and peak II protease were exchanged for 
EDTA-free buffer as in section 2. Samples (10 ~1) of peak 1 
protease (0) or peak II protease (A), at 0.4 units/ml and 
1.2 units/ml, respectively, were assayed for protease activity 
using succinylated bovine serum albumin substrate containing 
various concentrations of calcium. 
inhibitor at 0.1 mg/ml did not significantly inhibit 
either protease form. Thus, both protease forms 
appear to be divalent-cation requiring proteases which 
are inhibited by sulfhydryl modifying reagents. Similar 
properties have been described for Ca”-dependent 
proteases from rabbit skeletal muscle [4] and human 
platelets [ 181. 
3 S. Activation by Ca” 
Both protease forms were activated by the addition 
of Ca2’ (fig.3). The Ao.s of peak I protease for Cap 
was -40 PM. The activation of peak II protease 
yielded a sigmoidal saturation curve similar to curves 
described for a skeletal muscle Ca”-dependent pro- 
tease [4,7]. There was very little activity until Ca2+ 
was >400 PM. The Ao.s of peak II protease for Ca” 
was 800 PM. Although fig.3 indicates that peak I 
protease had activity in the absence of Ca’+, as little 
as 100 FM EDTA could abolish this activity com- 
pletely (data not shown). Therefore, it is likely that 
the protease activity observed in the absence of added 
Ca” in fig.3 was the result of trace amounts of Ca2+ 
or some other divalent cation in the reagents used in 
this experiment. 
4. Discussion 
Although there are reports of multiple forms of 
Ca”-dependent proteases, little has been done to 
characterize the isolated fractions. Three peaks of 
Ca”-dependent protease activity were found on ion- 
exchange chromatography of rabbit skeletal muscle 
extracts [6]. Only one of these protease activities 
removes muscle fiber Z-lines [6]. Major and minor 
peaks of Ca”-dependent protease were found on ion- 
exchange chromatography of rat brain extracts [2], 
but only the major activity peak (peak II) was studied. 
Two forms of Ca”-dependent protease from rabbit 
skeletal muscle were shown to differ in substrate 
specificity [ 111. The two canine cardiac protease 
activities described here are clearly related. They 
appear to have the same molecular weight (fig.2), 
very similar pH-activity profiles and similar sensitiv- 
ities to protease inhibitors. Peak I protease was a 
minor activity form of Ca2+-dependent protease in 
the canine cardiac preparation described above. 
However, it has been observed that peak I protease 
in extracts from fresh rabbit skeletal muscle represents a 
significant fraction of total Ca”-dependent protease 
activity [ 111. In some physiological conditions, peak 
I protease may perhaps be a major protease form in 
cardiac muscle. Studies to test this possibility are 
currently in progress. 
It is significant within the context of this work that 
the two Ca2’-dependent protease activities which have 
been purified to homogeneity from skeletal muscle 
[4,5] appear from their Ca’+ requirements to be peak 
II-type enzymes. Evidence that a peak I-type protease 
activity may be of paramount importance in the 
degradation of intracellular structural proteins is 
found in [8]. These investigators found that the pro- 
tease in crude brain extracts which attacked micro- 
tubule-associated proteins and prevented microtubule 
assembly had half-maximum activity in the presence 
of -50 PM Ca’+. Since peak I protease is present in 
dog heart and rabbit skeletal muscle, it is reasonable 
to expect that this protease form is of key importance 
in the Ca”-dependent proteolysis of muscle cell 
microtubules and other ultrastructures. 
Our current work is directed toward purification 
of the two canine cardiac proteases. These activities 
were unstable during further purification steps fol- 
lowing the DEAE-Sephadex chromatography step. 
Hence, it was not possible to purify either protease 
form to homogeneity. The apparent low concentra- 
tion of peak I protease in canine cardiac preparations 
further complicated attempts to purify this enzyme. 
Thus, it will probably be necessary to use large amounts 
of tissue to purify peak I protease to homogeneity. 
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